PROF. DR. POH MAU ERN
Department of Medicine
Faculty of Medicine
ernestpohum.edu.my| View CV | |
| View 1-Page CV | |
| Publons | |
| Biography | |
|
Professor Dr. Ernest Poh is Senior Consultant in Respiratory Medicine and Head of the Respiratory Unit at Universiti Malaya Medical Centre (UMMC). He is a recognized leader in bronchiectasis, COPD and lung cancer. Trained in lung oncology, he provides the latest therapy such as chemotherapy, targeted therapy and immunotherapy to patients. Prof Poh serves as faculty at international conferences and as principal investigator for clinical trials in lung cancer, COPD and bronchiectasis. He has secured over RM17 million in external grants and published extensively in high-impact journals, including Nature Medicine. Co-founder of the National Lung Cancer Disease Registry, Prof Poh also formed the UM Lung Cancer Multidisciplinary Tumor Board back in 2018, positioning UM as a hub for thoracic oncology. As Deputy Chair of the Malaysian Thoracic Society’s Lung Cancer Special Interest Group, he drives national clinical guidelines and symposiums. In education, Prof Poh mentors medical students and postgraduates, and serves as Clinical Coordinator for the undergraduate MBBS programme at Universiti Malaya. He is also a trainer and examiner for the Respiratory Subspecialty Examinations. He is an award-winning educator, receiving the Best Lecturer Award in 2018 and the Anugerah Cemerlang Universiti Malaya (ACUM) in 2025. |
|
Publication
Finance
| Project Title | Progress | Status |
|---|---|---|
| Lignosus Rhinocerus Tm02? As An Immunomodulatory Agent For The Treatment Of Uncontrolled Asthma And Allergic Rhinitis: A Randomised, Double Blind, Placebo-control Study |
|
end |
| This information is generated from Research Grant Management System | ||
Advancing Precision Medicine in Non-Small Cell Lung Cancer Diagnostics in a Southeast Asian Country
Geographic variation and clinical correlates of the bronchiectasis mycobiome: Data from the EMBARC-BRIDGE study
Does dose reduction of afatinib affect treatment outcomes of patients with <i>EGFR</i>-mutant metastatic non-small cell lung cancer in real-world clinical practice?
Diagnostic yield, detection of driver alterations by next-generation sequencing and safety of EBUS-guided mediastinal cryobiopsy versus needle aspiration: A retrospective comparative study
